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The Human Genome Revealed
James D. Watson
President, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Seeing the International Sequencing Con-
sortium’s draft of the human genome is
highly satisfying. The way in which its 3 bil-
lion bases have been determined closely fol-
lowed the course outlined more than a de-
cade ago by the National Academy of Sci-
ences (NAS) Committee on “Mapping and
Sequencing the Human Genome.” Bruce Al-
berts, now the President of the NAS, was its
chairman and I one of its 14 other members.
The predictions in our 1988 report, that the
human genome could be sequenced over a
15-year period for a cost of three billion dol-
lars, were more accurate than we dared guess.
Two more years of work, to fill in gaps and
correct mistakes, will result in an almost er-
rorless genetic script for human existence.
That the human script would become
available within our lifetimes never passed
through my mind or that of Francis Crick
when we found the double helix in 1953. At
that time, just learning how cells read the ge-
netic instructions within DNA seemed a tall
order. Happily, progress was faster than ex-
pected, and by 1966 we knew how the ge-
netic code utilizes groups of three DNA bases
to specify the amino acid constituents of pro-
teins—the main “actors” in the plays of life.
Things speeded up even more after the re-
combinant DNA procedures of Stanley Co-
hen and Herb Boyer burst upon the scene in
1973. Gene cloning and manipulation meta-
morphosed from being dreams to becoming
facts of life. Simultaneously, Fred Sanger and
Walter Gilbert each developed a powerful way
to determine the order of bases along DNA
molecules. This meant that humans, like cells,
could read the messages of genes. The way was
open to ascertain the complete genetic instruc-
tions, i.e. to sequence the genome, of any or-
ganism (subject to the usual constraints of
money, personnel, and technology).
The first genomes tackled were those of
viruses, with the first sequenced viral ge-
nomes containing only several thousand
bases. By the early 1980s, viral genomes con-
taining more than 100,000 bases had been
completed, and bacterial genomes contain-
ing more than a million bases became realis-
tic objectives. Completion of such genomes
would at last tell us the number of different
proteins necessary for bacterial existence. Back
then I thought that the human genome, at sev-
eral billion bases long, was much, much too
large to take on. Soon, however, I became a
strong proponent of an internationally-based
Human Genome Project (HGP), believing that
the large-scale mapping and sequencing re-
sources that it would command would greatly
hasten our discovery of the genetic underpin-
nings of many important human diseases.
Our NAS committee wasted little time
on whether we needed a HGP; instead we fo-
cused on how it should be organized and fi-
nanced. It seemed best to begin modestly and
end with a sequencing crescendo, hopefully
fueled by much lower sequencing costs. We
agreed unanimously that the first big se-
quencing efforts should not focus on human
DNA but on DNA from a model organism of
genetics, such as baker’s yeast and the fruit
fly, Drosophila. We knew that many human
genes were likely to be homologous to those
of model organisms, and these provided good
systems for studying gene function.
That we proposed a 15-year effort re-
flected our belief that those starting the
project should also be part of the finishing
team. Richard Gibbs, Eric Lander, Maynard
Olson, John Suiston, Bob Waterston, and
Jean Weissenbach all have stayed the course,
running increasingly larger megabase se-
quencing labs. Only one of our original NAS
committee is no longer in science. Sadly, Dan
Nathans died of leukemia three years ago, at
the age of 70. During our committee delib-
erations, no one proposed a shorter time
frame—technology had to improve too
much. Later, I learned that Congress likes big
projects to be finished within 10 years so that
key initial backers are still in Washington
when the achievement is celebrated. Luckily,
Tom Harkin recently became that Congress
rarity: a three-term Democratic senator from
Iowa. So, like New Mexico’s Republican Pete
Domenici, he will see the HGP from its be-
ginnings to its finish as a senator.
The improvements in technology that
the HGP would need for its success material-
ized almost on schedule. They largely in-
volved modifications in pre-existing meth-
ods, as opposed to great leaps forward that
generate Nobel Prize-like rewards. The cur-
rent DNA sequencing machines, the work-
horses of our big sequencing labs, are 1000-
fold-improved descendents of the original se-
quencing machine put together by Mike
Hunkepillar and Lloyd Smith in Lee Hood’s
Caltech lab. The computers and software that
now compare new raw DNA sequences to pre-
existing ones also do their tasks 1000 times
faster than was possible when the HGP began.
A major obstacle to the correct assembly
of the human genome was the vast amount
of the repetitive DNA (∼50%). So the HGP
labs decided early on to sequence DNA com-
ing from known chromosomal locations.
Their map-based strategy, however, was sud-
denly challenged in May 1998 by the new
private company Celera Genomics, led by
Craig Venter. Celera proposed an alternative
strategy whereby the genome was randomly
shredded into pieces that were sequenced and
then reassembled in a single process without
the construction of a map—a strategy known
as “whole-genome shotgun sequencing.” The
key to their approach was to be the 200 new,
high-capacity capillary DNA sequencers that
were about to be launched in the market, as
well as new proprietary shotgun assembly soft-
ware for use on high-powered computers. So
armed, Cetera promised a first draft of the hu-
man genome in only two years.
I first heard of Celera in a telephone call
from my former associate, Richards Roberts,
who organized the first (1988) Cold Spring
Harbor meeting on Genome Mapping and Se-
quencing. Rich told me that Celera would
blow the international consortium out of the
water and asked me to consider joining him
on its scientific advisory board. Expecting to
learn more about Celera’s game plan at our
soon-to-be-held spring 1988 Genome Meet-
ing, I quickly phoned the National Institutes
of Health (NIH) Genome Office and the Well-
come Trust to report that Celera had marked
them out for obsolescence. Later that week,
Craig Venter visited the NIH to tell Harold
Varmus and Francis Collins that the HGP’s
future effort might best be devoted to se-
quencing the mouse.
From the moment of Rich Roberts’s call,
I found it unthinkable that a private com-
pany should effectively control much of the
human genome through key patents. This
was a gene power-play that, at all costs, must
be contained. To my relief, the WellcomeArticle and publication are at http://www.genome.
org/cgi/doi/10.1101/gr.211601.
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Trust’s immediate response was to double the
budget for human genome sequencing at the
Sanger Centre. Although the merits of each
approach were yet to be tested, Celera’s “su-
per shotgun” method quickly caught the
fancy of the serious press, who reported that
the HGP was off-course. In fact, two years ear-
lier at its spring 1996 Bermuda meeting, HGP
leaders had seriously discussed Jim Weber’s
proposal for a low-resolution, whole-genome
shotgun effort to complement the high-
resolution map-based thrust. There, Phil
Green’s off-the-cuff calculations, later redone
and published (Green 1997), indicated that hu-
man DNA is too repetitive for a pure shotgun
approach to assemble the genome correctly.
In September 1998, I returned to Wash-
ington to tell key congressional leaders that
expanded federal support of the publicly-
funded sequencing effort was necessary to
prevent a monopoly on human genetic infor-
mation. Much of “big pharma” rooted for the
public HGP, believing that Celera’s future da-
tabases could only be validated through
checking with publicly obtained sequences.
To my relief, Congress increased public se-
quencing monies significantly. Thus encour-
aged, the HGP announced that it, like Celera,
would complete a rough draft of the human
genome in the spring of 2000. But unlike Cel-
era, it would further pursue a highly accurate
final product.
The February 2001 publications of the
human genome by the HGP (International
Human Genome Sequencing Consortium
2001) and Celera (Venter et al. 2001) repre-
sent a milestone in human history, revealing
the basic features of the human genetic
script. They will allow us to identify most of
the genes that underlie human existence. Us-
ing the genetic code to translate their mes-
sage into protein products, we now have the
first comprehensive overview of the mol-
ecules that make up our bodies. And it is im-
mediately obvious that these are very similar
to the molecular building blocks of other
forms of life. Darwinian evolution can be in-
creasingly described through incremental
changes in underlying DNA scripts.
It is, however, unclear whether either
draft is accurate enough for confident protein
structure predictions. In fact, proteome pre-
dictions from the two human drafts may be
seriously misleading; only a virtually errorless
“gold standard” human DNA script will move
us confidently into proteome waters. That so
much more sequencing needs to be done,
however, should in no way lessen our admi-
ration for what both groups have accom-
plished.
Until we saw the first DNA scripts under-
lying multicellular existence, it seemed natu-
ral that increasing organismal complexity
would involve corresponding increases in
gene numbers. So, I and virtually all of my
scientific peers were surprised last year when
the number of genes of the fruit fly, Dro-
sophila melanogaster, was found to be much
lower than that of a less complex animal, the
roundworm Caenorhabditis elegans (13,500 vs.
18,500). More shocking still was the recent
finding that the small mustard plant, Araba-
dopsis thaliana, contains many thousand
more genes (∼28,000) than does C. elegans.
Now we are jolted again by the conclusion
that the number of human genes may not be
much more than 30,000. Until a year ago, I
anticipated that human existence would re-
quire 70,000–100,000 genes.
Why organismal complexity fails to cor-
relate with gene numbers is not fully clear. It
may be partly due to RNA splicing events,
which generate multiple protein products
from single genes: Vertebrate genes give rise
to more splicing products than do inverte-
brate genes. But equally relevant may be the
quality of respective nervous systems. The
roundworm, being dumber than the fruit fly,
may need more specific proteins (and there-
fore genes) to respond to enemies or changes
in its environment; the fruit fly’s more ad-
vanced nervous system lets it respond to po-
tential enemies and stresses by flying away.
Plants, being totally dumb, must continually
evolve new genes to respond to new enemies
and climatic changes.
Many more vertebrate genomes need to
be sequenced before we have a sense of how
often the generation of new genes has under-
lain evolutionary change. We also need to
know why vertebrate genomes contain so
many more repetitive sequences than do in-
vertebrate genomes. Most human repetitive
sequences appear to have risen as the result of
the generation and movement of transpos-
able genetic elements. Conceivably, many of
the mutations that underlie vertebrate evolu-
tion arise from transposon movement into
regulatory regions, thus changing gene ex-
pression patterns. The very high levels of re-
petitive DNA in amphibians and lungfish
may reflect their past needs to evolve fast for
survival in their ever-changing ecological
niches.
It should be possible to test the idea that
changes in regulatory segments, as opposed
to changes in amino acid coding segments,
have dominated vertebrate evolution. For ex-
ample, sequencing information from mor-
phologically different breeds of dog may be
informative, and hopefully funds will be
made available to produce draft genomes of
several breeds. How soon we shall be able to
meaningfully compare the chimpanzee ge-
nome with that of our own, remains unclear.
Obviously we would like to know the genetic
changes that make possible the larger and
more powerful human brain.
Of the many new facts emerging from
the human genome draft, I am most excited
by the finding that repetitive sequences are
almost absent from the four clusters of ho-
meobox genes. Unlike most functionally-
related human genes, the chromosomal order
of homeobox genes reflects their temporal
expression patterns during embryonic devel-
opment. In this respect, they resemble the
genes of bacterial operons that are tran-
scribed from single messenger RNA mol-
ecules: Genes located at the start of bacterial
operons are transcribed first by RNA polymer-
ase molecules moving along their respective
region of DNA. Conceivably, much of early
developmental timing in humans may be a
reflection of the time needed for RNA poly-
merase molecules to transcribe the lengthy
introns of homeobox genes. If so, insertions
of sizable transposable sequences into them
would lethally mis-set key timing events in
embryonic development.
Many, many more unanticipated obser-
vations and hypotheses will emerge as the
reading of the human script extends beyond
those individuals who produced it, to the
much larger world of interested biologists.
Even the heartiest, however, will find them-
selves stretched if they take on too much. The
most triumphs of the near future will likely
come from focusing on human homologs of
genes functionally understood in one or
more model organisms. Eventually, even
more important dividends will come from fo-
cusing on ourselves as human beings and
making sense of the often-seemingly intrac-
table relationsbetween nature and nurture.
There is much more to human life than in-
teractions between its DNA script and the
RNA and protein “actors” that carry out its
instructions. The culturally-derived facts and
traditions that our brains pass onward from
one generation to the next equally affect our
lives.
Our genomes, thus, can never accurately
predict our futures. But we would be more
than silly if we did not use their information
to the fullest. The human genetic script that
we are now finalizing will be regarded as the
most important book ever to be read.
NOTE
Published in modified form from A Passion for
DNA: Genes, Genomes, and Society by James D.
Watson, (2001). Cold Spring Harbor Labora-
tory Press, Cold Spring Harbor, NY.
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